| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 7e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |